European Journal of Medicinal Chemistry p. 455 - 464 (2019)
Update date:2022-07-29
Topics:
Winters, Maria
DuHadaway, James B.
Pham, Khoa N.
Lewis-Ballester, Ariel
Badir, Shorouk
Wai, Jenny
Sheikh, Eesha
Yeh, Syun-Ru
Prendergast, George C.
Muller, Alexander J.
Malachowski, William P.
Tryptophan (Trp) catabolizing enzymes play an important and complex role in the development of cancer. Significant evidence implicates them in a range of inflammatory and immunosuppressive activities. Whereas inhibitors of indoleamine 2,3-dioxygenase-1 (IDO1) have been reported and analyzed in the clinic, fewer inhibitors have been described for tryptophan dioxygenase (TDO) and indoleamine 2,3-dioxygenase-2 (IDO2) which also have been implicated more recently in cancer, inflammation and immune control. Consequently the development of dual or pan inhibitors of these Trp catabolizing enzymes may represent a therapeutically important area of research. This is the first report to describe the development of dual and pan inhibitors of IDO1, TDO and IDO2.
View MoreChengdu Biopurify Phytochemicals Ltd.
website:http://www.phytopurify.com
Contact:+86-28-82633397
Address:2F,No.11 Building,No.388 Rongtaidadao CNSTP,Wenjiang Zone,Chengdu,Sichuan, China
Hangzhou Haiqiang Chemical Co.,Ltd.
Contact:+86-571-86960370
Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Guangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Laohekou Jinghong Chemical Co.,Ltd
Contact:+86-0710-3702747
Address:163.East,Huagong Road,Laohekou
Doi:10.1021/ol900779v
(2009)Doi:10.1016/0008-6215(87)85004-8
(1987)Doi:10.1016/j.jorganchem.2008.09.059
(2009)Doi:10.1002/jhet.5570390104
(1898)Doi:10.1021/acs.orglett.9b01192
(2019)Doi:10.1016/S0040-4039(00)96366-4
(1987)